RAPGEF1 and breast carcinoma: This pro-migratory effect of C3G silencing is in agreement with the enhanced migration observed in C3G-silenced CRC cells [55] and HCC cells [57] and with the inhibitory effect of C3G overexpression on breast carcinoma cell migration [58] (Figure 2 and Table 1).